Skip to main page content

Drug repurposing for Duchenne Muscular Dystrophy using phenotype-based drug screening

My Session Status

When:
11:30 AM, Monday 23 Nov 2020 (1 hour)
Where:
  Virtual session
This session is in the past.
The virtual space is closed.

Drug repurposing for Duchenne Muscular Dystrophyusing phenotype-based drug screening

Carrillo E1,2, Doyle J.J1,2, Parker J.A1,2 and Samarut É1,2

1Department of Neurosciences, University of Montréal Hospital Research Center (CRCHUM), Québec, Canada
2
Modelis inc., Montréal, Québec, Canada


Duchenne Muscular Dystrophy (DMD) is a rare genetic disorder and the most frequent among muscular diseases. It is due to the deficiency of a protein called dystrophin and is characterized by progressive weakness and degeneration of the skeletal muscles. Since no cure for DMD has yet been found, there is an urgent need to identify new therapies. With this aim, we believe that drug repurposing is a powerful alternative approach to bring potential new therapies to the bedside.

Our drug discovery approach is based on unbiased phenotype-based screening of already approved molecules using simple DMD genetic avatars: worms and fish. Using those, we screened more than 4,500 molecules against the motility defect of dmd-mutant worms and identified 20 that could significantly ameliorate their symptoms. Now we are validating their effect on dmd-mutant zebrafish using a combination of muscle integrity assay and movement quantification. Interestingly, we identified one lead compound that is able to significantly improve skeletal muscle integrity of dmd-mutant zebrafish after chronic exposure. We are now confirming the efficacy of our lead compound to restore muscle defects and prolong survival of dmd-mutant zebrafish. The next step will be to validate its efficacy in a mouse model of DMD and eventually to translate up to the clinic.

Who's Attending

Uday Praful Kundap
Dr
Université de Montréal
Nicolas Pilon
Directeur du CERMO-FC
UQAM
Nicolas Dumont
Université de Montréal
Benoît Vanderperre
Professeur adjoint
UQAM
Estefania Carrillo
Université de Montréal
Seda Yasa
CLN5 and CLN3 function as a complex to regulate endosome-to-TGN trafficking
INRS

My Session Status

Send Feedback

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages